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Cerebrovascular dysfunction is strongly associated
with neonatal intracranial hemorrhage (ICH) and
stroke in adults. Cerebrovascular endothelial cells
(ECs) play important roles in maintaining a stable
cerebral circulation in the central nervous system
by interacting with pericytes. However, the genetic
mechanisms controlling the functions of cerebral
ECs are still largely unknown. Here, we report that
disruption of Smad4, the central intracellular medi-
ator of transforming growth factor-b (TGF-b)
signaling, specifically in the cerebral ECs, results in
perinatal ICH and blood-brain barrier breakdown.
Furthermore, the mutant vessels exhibit defective
mural cell coverage. Smad4 stabilizes cerebrovas-
cular EC-pericyte interactions by regulating the tran-
scription of N-cadherin through associating with the
Notch intracellular complex at the RBP-J binding site
of the N-cadherin promoter. These findings uncover
a distinct role of endothelial Smad4 in maintaining
cerebrovascular integrity and suggest important
implications for genetic or functional deficiencies in
TGF-b/Smad signaling in the pathogenesis of cere-
brovascular dysfunction.
INTRODUCTION
Neonatal intracranial hemorrhage (ICH) is amajor complication of
prematurity that has an immense potential impact on morbidity,
mortality, and long-term neurodevelopmental sequelae (Ballabh,
2010; Bassan, 2009). Themost commonneonatal ICH—germinal
matrix hemorrhage-intraventricular hemorrhage (GMH-IVH)—
has a considerably high incidence rate of 20% in premature
infants. In addition to vascular anatomic vulnerability, paucity of
pericytes with relatively lower levels of transforming growth
factor-b (TGF-b) in the germinal matrix may lead to a propensityDeveloto hemorrhage (Ballabh, 2010; Bassan, 2009; Braun et al.,
2007). However, the genetic mechanisms underpinning the
fragile vasculature are still largely unknown.
Cerebrovascular endothelial cells (ECs) are interconnected by
complex tight junctions, form the blood-brain barrier (BBB), and
have the highest pericyte coverage. These features distinguish
brain endothelium from that of peripheral tissues and allow these
cells to adopt functional specialties in the central nervous system
(Abbott et al., 2006). Most recently, using pericyte-deficient
mouse models with defective platelet-derived growth factor
(PDGF) signaling, a direct role of pericytes in regulating BBB
function in vivo has been deciphered (Armulik et al., 2010; Bell
et al., 2010; Daneman et al., 2010). Furthermore, pericytes play
a key role in the maintenance of microvascular networks in the
adult and age brain (Armulik et al., 2010; Bell et al., 2010).
However, the molecular mechanisms underlying the specific
interactions between pericytes and cerebral ECs have not
been adequately investigated.
Members of the TGF-b superfamily transduce their signals
initially via specific cell surface receptors, and then through intra-
cellular mediators called Smads (Derynck and Zhang, 2003).
Mutations in TGF-b pathway genes, including ENDOGLIN,
ALK1, and SMAD4, have been acknowledged as genetic causes
of a vascular malformation syndrome, hereditary hemorrhagic
telangiectasia (HHT) (Berg et al., 1997; Gallione et al., 2004;
McAllister et al., 1994). Infants and children with a family history
of HHT are at risk for sudden and catastrophic ICH (Morgan
et al., 2002). Nevertheless, how intercellular communication
between ECs and mural cells is disturbed in HHT patients is by
far unknown. Mice deficient in various TGF-b signaling compo-
nents show embryonic death at mid-gestation due to vascular
defects (Dickson et al., 1995; Lan et al., 2007; Larsson et al.,
2001; Li et al., 1999; Oh et al., 2000; Oshima et al., 1996; Yang
et al., 1999), precluding a precise analysis of cerebrovascular
development, especially in the perinatal period when the BBB
develops.
The Notch pathway is evolutionarily conserved signaling
machinery that is essential for angiogenic sprouting, vascular
remodeling, and arteriovenous differentiation (Gridley, 2007).
Cross-talk between the TGF-b and Notch pathways in culturedpmental Cell 20, 291–302, March 15, 2011 ª2011 Elsevier Inc. 291
Figure 1. Targeted Disruption of Smad4 in Brain ECs Results in ICH and BBB Breakdown
(A) Double immunofluorescence on brain sections of E18.5 SP-A-Cre;ROSA26 double transgenic embryos using anti-CD31 (green) and anti-b-galactosidase
(b-Gal, red). Nuclei were stained with DAPI (blue). The same expression pattern of CD31 and b-Gal was visualized.
(B) Immunohistochemistry for Smad4 on E18.5 brain sections of SP-A-Cre;Smad4flox/+ (Control) and SP-A-Cre;Smad4flox/flox (Smad4fl/fl) embryos, showing
absence of Smad4 in the mutant cerebrovascular ECs.
(C) Polymerase chain reaction (PCR) analysis of genomic DNA from hearts (H) or brains (B) of mice with floxed Smad4 alleles (6) or Smad4fl/fl embryos showed
deletion of Smad4 specifically in the mutant brain ECs from E11.5.
(D) Control and Smad4fl/fl newborns. The mutants displayed increased head size indicative of ICH.
(E) Freshly isolated E17.5 embryonic brains. Cerebral (arrows) and cerebellar (arrowhead) hemorrhage of Smad4 mutants was detected.
(F) Hematoxylin and eosin (H&E) stained E18.5 (upper) or neonatal (lower) brain sections. Hemorrhage within the cerebrum (black arrows), inside the ventricle
(yellow arrowhead), in the submeninges (yellow arrow) or in the subarachnoid spaces (black arrowhead) of Smad4 mutants was demonstrated.
(G) Evans blue extravasation observed by fluorescencemicroscopy on frozen brain sections of newborns injectedwith Evans blue dye. Themutant one presented
much extended Evans Blue extravasation surrounding cerebral capillaries. Scale bar represents 40 mm (A), 10 mm (B), 500 mm (F), and 100 mm (G).
See also Figure S1.
Developmental Cell
Endothelial Smad4 and Cerebrovascular IntegrityECs has been reported, showing that Notch and bone morpho-
genetic protein (BMP) synergistically upregulate Hey1 expres-
sion to antagonize BMP-induced EC migration (Itoh et al.,
2004). Previous studies have also revealed that the selective
synergy between Notch and TGF-b signaling pathways plays
a critical role in the endothelial-to-mesenchymal transition (Fu
et al., 2009; Luna-Zurita et al., 2010). Nevertheless, functional
interactions between the two pathways in cerebrovascular ECs
remain largely unknown.
In this study, to gain better insights into the functions of Smad4
in cerebrovascular development, we inactivated the Smad4
gene specifically in cerebral ECs by using the Cre-LoxP strategy.
Deletion of Smad4 in cerebrovascular ECs recapitulated key
features of neonatal ICH with subsequent perinatal lethality.
Furthermore, Smad4-deficient ECs demonstrated impaired
interaction with pericytes along with downregulation of Notch
receptors and N-cadherin. Notably, Smad4-mediated TGF-b/
BMP signaling in cooperation with the Notch pathway modu-
lated N-cadherin expression to stabilize EC-pericyte associa-
tion. These findings reveal a molecular mechanism by which
EC-pericyte interaction and cerebrovascular integrity is main-292 Developmental Cell 20, 291–302, March 15, 2011 ª2011 Elseviertained during cerebrovascular development, and suggest the
brain EC-specific Smad4 deleted mouse as an intriguing animal
model for exploring pathophysiology of neonatal ICH.
RESULTS
Targeted Disruption of Smad4 in Brain ECs Results
in ICH and BBB Breakdown
To study the role of Smad4 in ECs in the developing brain
in vivo, we bred SP-A-Cre transgenic mice, in which Cre re-
combinase expression is restricted to brain vascular ECs
(Meng et al., 2007), with mice carrying floxed Smad4 alleles
(Yang et al., 2002), to generate SP-A-Cre;Smad4flox/+ (control)
and SP-A-Cre;Smad4flox/flox (Smad4fl/fl) mice. We first used
b-galactosidase and CD31 double immunofluorescent staining
to determine the EC-specificity of SP-A-Cre-mediated ablation
in the perinatal mouse brain (Figure 1A). We then used Smad4
immunohistochemistry and genomic polymerase chain reaction
(PCR) to confirm that Smad4 was absent in brain ECs in SP-
A-Cre;Smad4flox/flox mice (Figures 1B and 1C; see Figure S1A
available online).Inc.
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mutants displayed obvious macroscopic cerebral and/or cere-
bellar hemorrhage (Figures 1D and 1E). Massive intraventricular
hemorrhage (IVH) was observed in all Smad4 mutant mice (Fig-
ure S1B), which frequently caused enlargement of the ventricles.
Histological analysis revealed massive blood accumulation
within the cerebrum, inside the ventricle, in the submeninges,
and in the subarachnoid spaces (Figure 1F). To further investi-
gate BBB permeability in Smad4-deficient mice, Evans blue
dye was injected intraperitoneally into the newborns. Extravasa-
tion of Evans blue dye into the tissues surrounding the cerebral
capillaries was much more extensive in the mutants than in the
controls, indicating significantly increased BBB leakage
(Figure 1G).
Defective Cerebrovascular Architecture and Increased
Proliferation of Brain ECs in Smad4 Mutant Mice
Visualization of the cerebrovascular network by whole-mount
isolectin B4 immunostaining or by fluorescein isothiocyanates
(FITC)-labeled dextran perfusion demonstrated that the mutant
capillaries were distorted and variable in diameter (Figures 2A
and 2B; Figures S1C and S1D). Transmission electron micros-
copy revealed that themutant capillaries had thinner vessel walls
(Figure 2C). Quantification analysis showed that in the Smad4
mutant brains, microvascular length was normal, whereas both
the average and range of microvessel diameter was increased,
indicative of the irregular distension (Figure 2D; Figures S1C–
S1E). The dilation in Smad4 mutants was also evident in the
major vessels. High-resolution m-CT brain imaging, although
was done in low number of animals, demonstrated that the diam-
eter of mutant basilar artery was increased by a significant 37%
(Figure S1F). Arteries and veins, identified by double immunos-
taining of a-smooth muscle actin and Ephrin-B2 or EphB4,
were universally dilated with irregular lumen shapes (Figure 2E;
Figure S1G). Next, we analyzed the expression of a panel of
molecular markers for endothelial terminal differentiation and
BBB specification, including Von Willebrand factor, glucose
transporter 1, Claudin 5, and ZO-1. Therewas no apparent differ-
ence in either distribution or expression between the controls
and the mutants (Figures S1G–S1J). Tight junction structures,
which were identified by electron microscopy, were also de-
tected between adjacent ECs in the mutants (Figure S1H).
As shown by Ki67 and CD31 double-labeling, proliferation of
Smad4-deficient brain ECs was evidently increased (Figures 2F
and 2G). We further assessed the cell cycle status of primary
brain ECs in the culture by flow cytometry analysis. Corrobora-
tively, Smad4mutant-derived primary brain ECs were increased
in both the total number and the frequency of cells in S phase
(Figures 2H and 2I).
Impaired Mural Cell Coverage of Brain Vessels
in SP-A-Cre;Smad4flox/flox Embryos
We further investigated whether there was any defect in mural
cell coverage. As shown in Figures 3A–3E, the control cerebral
vasculature was completely enveloped by mural cells, which
were identified by NG2 or PDGF receptor-b (PDGFRb) immunos-
taining. In comparison, a local smooth muscle cell-coating defi-
ciency was observed in the arteries of Smad4mutant brains, and
consequent capsular aneurysmswere observed on vessel perfu-Develosion (Figure 3A). The defects were even more prominent in
Smad4 mutant microvessels, which exhibited patchy coverage
and poor association with mural cells (Figures 3B and 3E). Elec-
tron microscopy further corroborated the loose attachment of
pericytes to the surface of mutant capillaries (Figure 3F). The
morphological findings were further confirmed by quantification
analysis, showing normal pericyte number but reduced pericyte
coverage in Smad4 mutant microvessels (Figures 3G and 3H).
These results clearly showed that deletion of Smad4 in cerebro-
vascular ECs resulted in defective EC-mural cell contact, which
in turn might contribute to decreased mechanical stability and
a consequent collapse of cerebral vasculature.
Smad4-Deficient Brain ECs Show Decreased Barrier
Function and Three-Dimensional Tube Formation
in Coculture
To explore EC-pericyte interaction in vitro, weused two strategies
to obtain Smad4-deficient ECs. First, primary brain ECs were
isolated from SP-A-Cre;Smad4flox/+ and SP-A-Cre;Smad4flox/flox
brains as described previously (Song and Pachter, 2003)
(Figure 4A; Figure S2A). Second, we used RNAi to suppress
Smad4 expression in an immortalized mouse brain microvessel
EC line, bEnd.3, which displays basic characteristics of cerebral
microvascular ECs (Brown et al., 2007), or in a widely used pri-
mary EC type, human umbilical vein endothelial cells (HUVEC).
Primary pericytes were isolated as described (Nakagawa et al.,
2007), and no intrinsic proliferation or apoptosis defect was
detected in pericytes derived from Smad4 mutants (Figures
S2B–S2E). We used the same pericytes from Smad4-floxed
mice brains for all in vitro coculture assays, which mimicked the
in vivo conditions. Therefore, we could determine the defects
exclusively to the ECs.
To test whether Smad4 regulated the cerebral endothelial
permeability associated with EC-pericyte interactions, we used
an in vitro BBB model (Nakagawa et al., 2007) by coculturing
brain ECs with the primary pericytes (Figure 4B). When mono-
layer ECs were seeded on the transwell membrane in tracer
permeability assays, there was no apparent difference between
mutant and control ECs (Figure 4C). Coculture with pericytes
reduced the permeability in the control ECs to a greater degree
than in Smad4 mutant ECs, thus, the Smad4 mutant EC barrier
supported by pericytes was notably weaker than that of the
control (Figure 4C). Similar results were observed when primary
ECs were pretreated with mitomycin C to exclude the effect of
proliferation, or when the Smad4-siRNA brain EC line, bEnd.3,
was utilized (Figures S2F–S2H).
To further validate the defect in EC-pericyte interaction, we
performed an in vitro three-dimensional coculture system, in
which both ECs and pericytes are morphologically stretched
and synergistically associated to form capillary-like structures
(Darland and D’Amore, 2001). With the same primary peri-
cytes, Smad4-siRNA ECs demonstrated significantly impaired
tube-forming capacity in the coculture compared to the
control-siRNA ECs (Figures 4D–4H; Figures S2I and S2J).
Morphologically, Smad4-siRNA HUVECs showed inefficient
elongation and connection with pericytes (Figure 4E; Fig-
ure S2J). Notably, when increased numbers of ECs were
added, tube formation in the coculture with Smad4-siRNA
ECs did not increase as it did in the control coculture, implyingpmental Cell 20, 291–302, March 15, 2011 ª2011 Elsevier Inc. 293
Figure 2. Disrupted Cerebral Vasculature and Increased Brain ECs Proliferation in Smad4 Mutant Mice
(A) Whole-mount isolectin B4 immunostaining of spinal cord showed defective vasculature in themutants. Lower panels aremagnified views of boxes indicated in
upper panels.
(B) Whole-mount views of cerebral vasculature from newborns perfused with FITC-labeled dextran demonstrated irregularly dilated brain capillaries in the
mutants.
(C) Transmission electron microscopy of E18.5 cerebral capillaries detected increased lumen size and reduced vessel wall thickness of the mutants. Red aster-
isks indicate red blood cells outside the vessels.
(D) Quantification of the cerebellar microvessel diameter in the comparable areas showed increased both range and average in Smad4mutants, indicative of the
irregular distension.
(E) Ephrin-B2 (red) and a-smooth muscle actin (a-SMA, green) double immunostaining on E18.5 brain sections manifested enlarged arteries (arrowheads) and
veins (arrows) but normal arteriovenous specification in Smad4 mutants.
(F) Ki67 and CD31 double-immunostaining on E18.5 brain sections.
(G) Quantification of Ki67 positive ECs showed a significant increase in the mutants. Four animals for each genotype were checked. Totally 30 vessels from four
representative sections for each genotype were calculated.
(H) Increased frequency of ECs (CD31+) in primary brain cells culture derived from Smad4 mutants (detected by flow cytometry, n = 5).
(I) Cell cycle analysis of CD31+ cells in primary brain cells culture synchronized by thymidine, showing increased frequency in S phase of the Smad4 mutants.
n = 3. Values are the means ± standard deviation (SD). **p < 0.01, *p < 0.05. Scale bar represents 200 mm; upper in (A) and 40 mm; lower in (A), (B), (E), and (F).
See also Figure S1.
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EC-pericyte interactions (Figure 4F). These results strengthen
the assertion that loss of Smad4 signaling in ECs impairs
EC-pericyte interaction.294 Developmental Cell 20, 291–302, March 15, 2011 ª2011 ElsevierN-Cadherin Facilitates EC-Pericyte Interactions
Mediated by Endothelial Smad4
To identify potential Smad4 target genes that control cere-
brovascular integrity in brain ECs, a microarray assay wasInc.
Figure 3. Impaired Mural Cell Coverage of Brain Vessels in SP-A-Cre;Smad4flox/flox Embryos
(A and B) Whole-mount NG2 (red) immunostaining of neonatal brain tissues after vessel perfusion with FITC-labeled dextran (green). Representative arteries
(A) and microvessels (B) are shown. Arrowhead indicates local smooth muscle cell coverage defect in the mutant artery. Smad4mutant microvessels manifested
patchy coverage and poor association of pericytes.
(C) PDGFRb (red) and CD31 (green) double immunostaining on E18.5 brain sections showed discontinuous pericytes (arrowhead) in the Smad4 mutants.
(D and E) NG2 (red) andCD31 (green) double immunostaining on E18.5 brain sections demonstrated pericyte coverage defects (arrowheads) inSmad4mutants at
both arteriole (D) and capillary (E) level. Arrow indicates a rupture of the vessel wall.
(F) Transmission (upper) and scanning (lower) electron microscopy of E18.5 brain tissues showed detachment of pericytes (PC) from Smad4mutant endothelial
layer (EC). Arrowheads point to the obvious gaps between pericytes and subjacent mutant ECs.
(G) Quantification of pericyte number (NG2+ pericytes permm2 of CD31+ capillary area) in the cerebrum of E18.5 embryos, showing no difference betweenSmad4
mutants and the controls.
(H) Quantification of pericyte coverage of capillaries (percentage of PDGFRb+ pericyte surface area covering CD31+ capillary surface area) in the cerebrum and
cerebellum of E18.5 Smad4 mutant and control embryos. Values are the means ± SD. **p < 0.01. Scale bar represents 80 mm (A), 20 mm (B–E), and 2 mm (F).
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cells transfected with Smad4-siRNA and control-siRNA (Table
S1). We further verified some expression changes of the genes
involving matrix-degrading metalloproteinases (MMPs), Notch
pathway, VEGF family, and Eph/Ephrin family (Figures S3A–
S3D). Expression in pericytes derived from Smad4mutant brains
was also analyzed. Interestingly, altered expressions in TGF-b1,
PAI-1, Fibronectin 1, Id1, and Id3 were observed in pericytes of
Smad4 mutants, reflecting somewhat disturbed TGF/BMP
signaling (Figures S3E–S3H). Of particular interest was the
remarkable decrease in N-cadherin in both Smad4-siRNA
bEnd.3 cells and primary Smad4-deficient brain ECs (FiguresDeveloS3A and S3B). We further examined the in situ expression of
N-cadherin by immunofluorescent staining. In whole-mount
views, N-cadherin was patchily expressed in brain capillaries
derived from control mice, whereas expression in Smad4-
deficient brain microvessels was dramatically decreased relative
to the vessel wall (Figure 5A). To visualize the localization of
N-cadherin at the cellular level, primary brain ECs were isolated
and cocultured with pericytes. In the cultures with control ECs,
the distribution of N-cadherin along the cell borders between
ECs and pericytes was induced when cell contact occurred. In
contrast, Smad4-deficient ECs manifested markedly decreased
staining along the cell borders (Figure 5B).pmental Cell 20, 291–302, March 15, 2011 ª2011 Elsevier Inc. 295
Figure 4. Deletion of Smad4 in Brain ECs Leads to Decreased Barrier and Three-Dimensional Tube Formation in EC-Pericyte Coculture
(A) Real-time PCR analysis of Smad4 transcripts in primary isolated brain ECs derived from Smad4flox/flox, SP-A-Cre;Smad4flox/+, and SP-A-Cre;Smad4flox/flox
embryos.
(B) The in vitro BBB model showed how endothelial monolayer or EC-pericyte coculture was seeded on the transwell membrane.
(C) The quantification of Na-F and FITC-dextran permeability showed increased permeability to the tracers in Smad4 mutant primary brain ECs than in controls
when cocultured with the wild-type primary pericytes.
(D) Real-time PCR analysis of Smad4 expression in control- and Smad4-siRNA HUVECs showed a 50% RNAi efficiency.
(E) Three-dimensional tube formation by coculturing HUVECs (green) and pericytes on Matrigel. Smad4-siRNA HUVECs showed impaired morphological
changes to associating with pericyte to form tube-like structures. Red arrowheads point to HUVECs. White arrows indicate pericytes. Inserts are the bright field
views of the corresponding panels.
(F) Quantification of total tube length as different EC/pericyte ratios were used in the coculture.
(G) RT-PCR (upper) and western blot (lower) analysis of Smad4 expression in Control- and Smad4-siRNA bEnd.3 cells. Quantification of the expression level by
Image-Pro Plus was shown to the right.
(H) Quantification of the tube formation in the coculture using bEnd.3 cells. The coculture involving Smad4-siRNA bEnd.3 cells exhibited dramatically reduced
tube number (left) and total tube length (right). Values are the means ± SD. **p < 0.01, *p < 0.05. Scale bar represents 100 mm (E).
See also Figure S2.
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interaction, we suppressed N-cadherin expression by RNAi and
demonstrated at least 80% downregulation (Figure 5C). Similar296 Developmental Cell 20, 291–302, March 15, 2011 ª2011 Elsevierto the Smad4-siRNA ECs, N-cadherin-siRNA ECs showed
increased permeability and disturbed capillary tube formation
in the EC-pericyte coculture systems (Figures 5D and 5F).Inc.
Figure 5. N-cadherin Facilitates EC-Pericyte Interactions Mediated by Endothelial Smad4
(A) Confocal images of E18.5 brain tissues immunostained with N-cadherin (green) and VE-cadherin (red) showingmarkedly decreased expression of N-cadherin
relative to the vessel wall in the Smad4 mutants.
(B) N-cadherin (red) immunostaining on primary brain ECs and pericytes (green) coculture showing reduced N-cadherin expression (arrowheads) along the heter-
ologous cell border in Smad4 mutants.
(C) Real-time PCR (left) andwestern blot (right) analysis of N-cadherin expression in Control- and N-cadherin (Cdh2)-siRNA bEnd.3 cells, demonstrating an80%
downregulation.
(D) The in vitroBBBmodel showed increased FITC-dextranpermeability inN-cadherin-siRNAECs than in controlswhen coculturedwith the sameprimary pericytes.
(E and F) Quantification of three-dimensional tube formation by coculturing ECs and pericytes on Matrigel showed decreased tube number (E) and total tube
length (F) of N-cadherin-siRNA ECs in the coculture.
(G) Western blot of N-cadherin expression in primary brain ECs electroporated with vector control or N-cadherin overexpression constructs.
(H) Quantification of FITC-dextran permeability showed decreased coculture/monolayer permeability ratios on N-cadherin overexpression and a considerable
rescue of Smad4 mutant coculture with N-cadherin overexpression in the Smad4-deficient ECs. Values are the means ± SD. **p < 0.01. Scale bar represents
10 mm (A) and (B).
See also Figure S3 and Table S1.
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Figure 6. TGF-b/BMP and Notch Pathways Cooperatively Upregulate N-cadherin Expression in Brain ECs
(A) Western blot analysis of N-cadherin in isolated primary brain ECs pretreated with GSI 6 hr followed by TGF-b1 or BMP4 for another 6 hr.
(B) bEnd.3 cells were transfected with different luciferase reporter constructs. The reporter gene assays showed that both TGF-b1 and BMP4 treatments
increased the activity of N-cadherin promoter containing a conserved RBP-J binding site, which were largely abrogated by GSI. The roles of TGF-b1, BMP4,
and GSI on the reporter were completely abolished as the RBP-J binding site was mutated. No responsiveness was detected as cells were transfected with
construct lacking the RBP-J binding site.
(C) bEnd.3 cells were treated with GSI 18 hr followed by TGF-b1 or BMP4 for another 6 hr. Smads coprecipitated proteins were resolved by western blot for
Notch1 intracellular domain (N1ICD) expression.
(D) Primary brain ECs were treated with GSI 18 hr followed by TGF-b1 or BMP4 for another 6 hr and subjected to ChIP with anti-Smad1/5/8, anti-Smad2/3, anti-
Smad4, or anti-RBP-J. The DNA fragments were amplified by PCR using primers for the N-cadherin promoter region 664 to 487 bp containing the 603 bp
RBP-J binding site. A nonbinding region (2732 to 2571) was served as a negative control for PCR amplification.
(E and F) Immunohistochemistry for PDGFRb (E) and NG2 (red) and CD31 (green) double immunostaining (F) on E18.5 cerebellum sections. Knob-like pericytes
(arrows) and focally absent coverage (arrowheads) were demonstrated in the RBP-J mutants.
(G) H&E stained E18.5 brain sections of SP-A-Cre;RBP-Jflox/+ (RBP-Jfl/+) and SP-A-Cre;RBP-Jflox/flox (RBP-Jfl/fl) embryos showing hemorrhage within the cere-
brum of RBP-J mutants.
Developmental Cell
Endothelial Smad4 and Cerebrovascular Integrity
298 Developmental Cell 20, 291–302, March 15, 2011 ª2011 Elsevier Inc.
Developmental Cell
Endothelial Smad4 and Cerebrovascular IntegrityTo further illustrate the potential involvement of N-cadherin in the
impaired EC-pericyte interactions in Smad4 mutants, rescue
experiments were performed by using an overexpression
strategy. Isolated primary brain ECs were transfected with an
N-cadherin overexpression construct (Figure 5G). The results
showed decreased coculture/monolayer permeability ratio in
N-cadherin overexpression groups compared to the vector
control groups, indicating that the barrier supported by EC-peri-
cyte interaction was strengthened when ECs overexpressed
N-cadherin (Figure 5H). Importantly, Smad4-deficient brain
ECs that overexpressed N-cadherin manifested a 38.3% cocul-
ture/monolayer permeability ratio, resembling that of control
cells without N-cadherin overexpression, indicative of a consid-
erable rescue by N-cadherin overexpression (Figure 5H). These
results demonstrated that impaired EC-pericyte interaction in
Smad4 mutant brains might be largely due to the reduced
N-cadherin expression.The TGF-b/BMP and Notch Pathways Cooperatively
Upregulate N-Cadherin Expression
in Cerebrovascular ECs
We explored the possible mechanism by which N-cadherin
expression was regulated, and found amechanistic link between
TGF-b/BMP and Notch. We found altered expression of several
Notch family members in the Smad4mutants, including downre-
gulation of two receptors, Notch1 and Notch4, which are ex-
pressed mainly in ECs where they have pivotal roles (Gridley,
2007) (Figure S3A and Table S1). Combined with the obvious
reduction in the Notch direct targets Hes1, Hey1, and Hey2 (Fig-
ure S3B), the results indicated that Notch signaling is disturbed in
Smad4-deficient ECs.
As shown in Figure 6A, inhibiting endogenous Notch activity
by g-secretase inhibitor (GSI) treatment decreased N-cadherin
expression in primary brain ECs. BMP4 or TGF-b1 treatment
increased N-cadherin expression, and both were largely abro-
gated by GSI treatment (Figure 6A), strongly suggesting that
TGF-b/BMP-regulated N-cadherin expression was largely
dependent on Notch activation. Notch signals via the direct
association of Notch intracellular domain (NICD) with the tran-
scription factor RBP-J (also known as CSL or CBF-1).
Sequence analysis of the N-cadherin promoter identified
a typical RBP-J binding site at position 613 bp. Therefore,
we performed luciferase reporter assay to determine the
direct regulation of N-cadherin transcription by Notch and
TGF-b/BMP signaling. When cells were transfected with the
luciferase construct that included the RBP-J binding site,
promoter activity was enhanced with BMP4 or TGF-b1 treat-
ment, and both increases were largely blocked in the absence
of endogenous Notch activity (Figure 6B). However, both the
inhibition by GSI and the enhancement by TGF-b1 or BMP4
on the reporter were completely abolished when the RBP-J
binding site was mutated, confirming the selective importance
of the RBP-J binding site and the specificity of the transcrip-
tional activation (Figure 6B).(H) Western blot analysis of N-cadherin expression in isolated primary brain ECs
(I) Whole-mount N-cadherin (red) and isolectin B4 (green) double immunostaining
vessel wall in RBP-J mutants. Values are the means ± SD. Scale bar represents
DeveloNext, we examined whether Notch and Smads physically in-
teracted on this RBP-J binding site. We carried out chromatin
immunoprecipitation assay (ChIP) assays in ECs that were
pretreated with GSI followed by TGF/BMPs treatments. Western
blot after ChIP showed that Notch1 intracellular domain (N1ICD)
was detected in both Smad1/5/8- and Smad2/3-containing
complexes, suggesting that Smads physically associated with
N1ICD (Figure 6C). Notably, TGF-b1 treatment significantly
increased N1ICD in Smad2/3-containing complex, whereas
treatment with GSI evidently blocked this effect (Figure 6C).
DNA that coprecipitated with Smads was further analyzed by
PCR, using primers specific for the region containing
the 613 bp RBP-J binding site on the N-cadherin promoter.
As shown in Figure 6D, all the antibodies used here, including
Smad1/5/8, Smad2/3, Smad4, and RBP-J antibodies, pulled
down the RBP-J binding region. Moreover, TGF-b1 treatment in-
creased PCR products in Smad2/3-, Smad4-, and RBP-J -con-
taining complexes, and BMP4 increased the binding of Smad1/
5/8, Smad4, and RBP-J to the RBP-J binding site. In addition,
GSI treatment reduced all these increases to basal levels (Fig-
ure 6D). Similar results were observed in the ChIP assay per-
formed using bEnd.3 cells (data not shown). These results
strongly suggested that Smads formed a complex with NICD
and RBP-J, and that TGF-b/BMPs enhanced recruitment of the
complex to the RBP-J binding site on the promoter to transacti-
vate N-cadherin.
Given the finding that Notch signalingmight be disturbed in the
Smad4mutants, we generated brain EC-specific RBP-J-deleted
mice (SP-A-Cre;RBP-Jflox/flox), by breeding SP-A-Cre transgenic
mice with RBP-J floxed mice (Han et al., 2002), to investigate
the possible role of Notch signaling in cerebrovascular integrity.
We examined pericyte coverage in RBP-J mutant mouse brain
and detected some knob-like pericytes and focally absent
coverage in RBP-J mutant cerebellum (Figures 6E and 6F).
Importantly, we witnessed a perinatal ICH (Figure 6G) and
remarkably decreased N-cadherin expression in cerebro-
vascular ECs of SP-A-Cre;RBP-Jflox/floxmice (Figures 6H and 6I).DISCUSSION
The present study reveals an essential role for endothelial Smad4
in the maintenance of cerebrovascular integrity. We show that
endothelial Smad4-mediated TGF-b signaling is required for sta-
bilizing the interaction between cerebrovascular ECs and peri-
cytes. Furthermore, we provide a mechanistic link between
TGF-bandNotch signaling inmaintainingcerebral vascular integ-
rity, which has important implications for the treatment of ICH.
The development of cerebral vasculature and its regulatory
mechanisms are quite distinct from those of other tissues (Ab-
bott et al., 2006). Targeted disruption of those genes generally
essential for blood vessel development, including Angiopoietins
and their Tie receptors, select members of the Notch families,
and components of the TGF-b signaling pathway, invariably
lead to lethality during early embryogenesis (Armulik et al.,demonstrating a dramatic downregulation in RBP-J mutants.
of E18.5 brain tissues showing reduced N-cadherin expression relative to the
20 mm (E), (F), and (I) and 150 mm (G).
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deleted mice die at E10.5 with defects in the recruitment of
pericytes, thus not suitable for studying the function of Smad4-
mediated TGF-b signaling in cerebrovascular EC-pericyte inter-
actions (Lan et al., 2007). Therefore, genetic mechanisms
governing cerebral vasculature development remain elusive. In
this study, we developed a cerebrovascular EC-specific gene
knockout mouse, with which the physiological functions of
Smad4 in cerebrovascular ECs could be evaluated without
affecting cardiogenesis or peripheral blood vessel development.
Disruption of the Smad4 gene specifically in brain ECs invari-
ably led to impaired vascular integrity and consequent fatal ICH.
Nowadays, most GMH-IVH or ICH mouse models are generated
via autologous blood injections to study the brain damages that
occur after hemorrhage (Balasubramaniam and Del Bigio, 2006;
Rynkowski et al., 2008). However, genetically modified mouse
models of ICH are still lacking. In this study, we observed
a number of pathologic characteristics of neonatal ICH in
Smad4 mutants, including dilation of the vascular lumen, thin-
ning of the vascular wall, and the frequent presence of aneu-
rysms in cerebral vasculature. Furthermore, all the Smad4
mutant mice displayed massive IVH (Figure S1B), a typical path-
ological characteristic of GMH-IVH. Our findings suggest that
cerebrovascular EC-specific Smad4 mutant mice are extremely
useful animal models for exploring the pathophysiology of
neonatal ICH. Noteworthily, the incidence of ICH is higher in
the HHT patients with SMAD4 mutations than in those carrying
ENDOGLIN or ALK1 mutations (Gallione et al., 2004), although
thus far no genetic data exist with humans that early postnatal
ICH is associated with SMAD4 deficiency.
Pericytes are required for maintaining microvascular integrity
and BBB function during development (Daneman et al., 2010;
Lindahl et al., 1997). TGF-b signaling has been acknowledged
as pivotal in the differentiation of vascular smooth muscle
cells/pericytes at mid-gestation, as revealed by gene knockout
studies on the signal components, including TGF-b1, Tgfbr2,
Alk1, Alk5, endoglin, Smad5, and Smad4 (Dickson et al., 1995;
Lan et al., 2007; Larsson et al., 2001; Li et al., 1999; Oh et al.,
2000; Oshima et al., 1996; Yang et al., 1999). In comparison,
this study strongly suggests that endothelial Smad4 functions
by regulating EC-pericyte interactions, rather than by affecting
the number or viability of pericytes, to stabilize cerebrovascular
integrity at the prenatal stage.
The mechanism behind the role of endothelial TGF-b signaling
in facilitating EC-pericyte interaction is by far unknown. Here, we
provided functional evidences that N-cadherin played a pivotal
role in brain endothelial Smad4-mediated EC-pericyte interac-
tions. N-cadherin is required for pericyte recruitment and vessel
stabilization (Paik et al., 2004; Tillet et al., 2005). Neutralization
of N-cadherin in the developing chicken brain results in defective
pericyte adhesion to the brain vessels, indicative of its pivotal
role in mediating EC-pericyte association during brain angiogen-
esis (Gerhardt et al., 2000). Thus far, physiological role of N-cad-
herin in EC-pericyte interactions remains elusive, as deletion of
N-cadherin in ECs results in embryonic lethality at mid-gestation
due to severe vascular defects (Luo and Radice, 2005). RhoGT-
Pases activity has been implicated in N-cadherin-dependent
adhesion (Paik et al., 2004). Furthermore, Rac/Rho effectors
are known to mediate microvascular barrier functions and300 Developmental Cell 20, 291–302, March 15, 2011 ª2011 ElsevierBMP2-induced angiogenesis (de Jesus Perez et al., 2009;
Spindler et al., 2010). However, it remains to be determined
whether N-cadherin-mediated RhoGTPases activation is
involved in defective EC-pericyte interaction in Smad4 mutants.
MMPs-mediated N-cadherin cleavage has been implicated in
N-cadherin-induced vascular smooth muscle cell proliferation
and apoptosis (Dwivedi et al., 2009; Williams et al., 2010). In
this study, viability and N-cadherin expression of mural cells
were not altered in the Smad4 mutants, although we witnessed
an obvious disturbed expression of MMPs in the mutant brains
(Table S1 and Figure S3C). Whether the altered MMPs expres-
sion in Smad4 mutants could also contribute to the phenotypes
needs to be further investigated.
This study provides direct genetic evidence linking Smad4-
mediated TGF-b signaling and the Notch pathway in an impor-
tant physiological system. Previous studies have shown that
TGF-b can upregulate N-cadherin expression in epithelium,
keratinocytes, and myofibroblasts through Smad-dependent or
Smad-independent mechanisms (Bhowmick et al., 2001; De
Wever et al., 2004; Diamond et al., 2008). Notch1 activation
can also upregulate N-cadherin expression in tumor cells (Liu
et al., 2006). Accumulating experimental data have revealed
synergy and antagonism between Notch and TGF-b signaling
in controlling cell proliferation, differentiation andmigration (Carl-
son et al., 2008; Dahlqvist et al., 2003; Itoh et al., 2004; Kurpinski
et al., 2010; Tang et al., 2010). Here, we identified a mechanistic
connection between Smad4-mediated TGF-b signaling and
Notch signaling in brain ECs where TGF-b/BMPs facilitate the
transactivation of N-cadherin, which largely depends on Notch
activation. Corroboratively, cerebrovascular specific RBP-J
gene knockout mice displayed downregulated N-cadherin as
well as intracranial bleeding.
EXPERIMENTAL PROCEDURES
Mouse Strains
Mice carrying floxed Smad4 alleles (Yang et al., 2002), mice with floxed RBP-J
alleles (Han et al., 2002), SP-A-Cre transgenic mice (Meng et al., 2007), and
ROSA26 reporter mice (Soriano, 1999) were reported previously. Littermates
were used in all experiments. Animals were handled in accordance with insti-
tutional guidelines. Genotyping was performed as described previously (Meng
et al., 2007).
Vessel Perfusion, Immunostaining, and Histology
Newborns were perfused though the left ventricle with 1.25% FITC-labeled
dextran (MW 2,000,000, Sigma) containing 2.5% gelatin (50 ml/g body weight).
Then the brains were dissected, fixed with 1% paraformaldehyde for 1 hr.
The vasculature was observed by fluorescence microscopy. Whole-mount
immunostaining was performed as described (Lan et al., 2007). Hematoxylin
and eosin staining and immunostaining were preformed using standard proce-
dures. Percentage of Ki67-positive ECs was calculated by counting relative
proportion of Ki67/CD31 double positive to CD31 positive cells in each vessel
on scanned images from representative sections. See Supplemental Experi-
mental Procedures for information about the antibodies.
Morphological Quantification
Measurement ofmicrovessel diameter was performed as follows: based on the
Isolectin B4 staining of 50-mm thick sections, images were captured at the
comparable areas, ten equidistance and parallel lines were set, and the cross
points were selected for vascular diameter analysis by AxioVision software.
Representative image views (650 3 650 mm) for the calculating were shown
in Figures S1C and S1D. Three mice for each genotype and totally 20 views
from five sections for each individual were checked. Quantification wasInc.
Developmental Cell
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pericyte number andpericyte coveragewasperformed asdescribed (Bell et al.,
2010). Pericyte number was expressed as NG2+ pericytes per mm2 of CD31+
capillary area. Nine corresponding areas in three animals of each genotype
were analyzed. Pericyte coverage was expressed as a percentage (%) of
PDGFRb+ pericyte surface area coveringCD31+ capillary surface area. Six cor-
responding areas in three animals of each genotype were analyzed.
Cell Culture
The bEnd.3 cell line was purchased from ATCC. HUVEC, primary brain ECs,
and pericytes were isolated and cultured as described (Crampton et al.,
2007; Nakagawa et al., 2007; Song and Pachter, 2003). Pericytes or HUVECs
were pretreated with CellTraker (Invitrogen) according to manufacturer’s
instructions as needed. See Supplemental Experimental Procedures for
gene overexpression and RNAi-mediated knockdown.
In Vivo and In Vitro Permeability Assays
Evans blue (4% wt/vol) was intraperitoneally injected into the newborns, and
systematic distribution of the dye was confirmed by a change in skin color
>2 hr after injection. After decapitation, the brains were immediately frozen
in nitrogen, sectioned at 8 mm and mounted. Autofluorescence of Evans blue
was observed by fluorescence microscopy. In vitro permeability assays
were performed as described (Nakagawa et al., 2007). The concentration of
sodium fluorescein (Na-F, MW 376, Sigma) or FITC-conjugated dextran (MW
40,000, Sigma) was determined with an EnVision fluorescence multiwell plate
reader (Perkin-Elmer) using a fluorescein filter pair (Ex(l) 480 nm; Em(l)
535 nm). The percentages of control were quantified. In some cases, mito-
mycin C was used at 10 mg/ml to block cell proliferation and cells were
analyzed 2 hr later.
In Vitro Tube Formation Assay
ECs and primary pericytes were mixed and replated to 48-well plates pre-
coated with a thin layer of Matrigel (BD Biosciences) in culture medium con-
taining 5% FCS, and allowed to form tube-like structures for 12–36 hr.
Measurement was performed as described (Lan et al., 2007).
Reporter Assay
DNA fragments1229 bp to +432 bp of N-cadherin gene with or without RBP-
J binding site mutated (tCCGCa to gAATTc), and 495 bp to +432 bp of
N-cadherin gene were introduced to the pGL3-basic vector (Promega),
respectively. bEnd.3 cells in 24-well plates were transfected with different
reporter constructs. Twenty-four hours later, the cultures were treated with
GSI for 6 hr followed by BMP4 or TGF-b1 for another 6 hr. Luciferase activities
were detected with Dual-luciferase reporter assay reagents (Promega).
Chromatin Immunoprecipitation Assay
Isolated primary brain ECs or bEnd.3 cells were pretreated with GSI, BMP4 or
TGF-b1 as needed. A ChIP kit was used for the assays according to manufac-
turer’s instructions (Upstate Biotechnology). See Supplemental Experimental
Procedures for information about the reagents and primer sequences.
Statistical Methods
Data were evaluated using a Student’s 2-tailed t test. *p < 0.05 and **p < 0.01
was taken to be statistically significant. The error bars on graphs represent the
mean ± standard deviation (SD).
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deposited in the NCBI Gene Expression Omnibus and are accessible through
GEO Series accession number GSE15736.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
doi:10.1016/j.devcel.2011.01.011.DeveloACKNOWLEDGMENTS
We thank Chuxia Deng for mice with floxed Smad4 alleles; Yeguang Chen for
anti-Smad1/5/8 antibodies; and Qiang Sun for Smad4-siRNA plasmid. This
work was supported by Key Project for Drug Discovery and Development in
China (2009ZX09501-027), Chinese National Key Program on Basic Research
(2011CB964803, 2011CB504200), Key Project for the Infectious Diseases in
China (2009ZX10004-401), National Natural Science Foundation of China
(31030040, 30770450, 30800393, 30871437), and Beijing Natural Science
Foundation (5092024).
Received: August 5, 2010
Revised: December 31, 2010
Accepted: January 19, 2011
Published: March 14, 2011REFERENCES
Abbott, N.J., Ronnback, L., and Hansson, E. (2006). Astrocyte-endothelial
interactions at the blood-brain barrier. Nat. Rev. 7, 41–53.
Armulik, A., Abramsson, A., and Betsholtz, C. (2005). Endothelial/pericyte
interactions. Circ. Res. 97, 512–523.
Armulik, A., Genove, G., Mae, M., Nisancioglu, M.H., Wallgard, E., Niaudet, C.,
He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010). Pericytes regulate
the blood-brain barrier. Nature 468, 557–561.
Balasubramaniam, J., and Del Bigio, M.R. (2006). Animal models of germinal
matrix hemorrhage. J. Child Neurol. 21, 365–371.
Ballabh, P. (2010). Intraventricular hemorrhage in premature infants: mecha-
nism of disease. Pediatr. Res. 67, 1–8.
Bassan, H. (2009). Intracranial hemorrhage in the preterm infant: under-
standing it, preventing it. Clin. Perinatol. 36, 737–762.
Bell, R.D., Winkler, E.A., Sagare, A.P., Singh, I., LaRue, B., Deane, R., and
Zlokovic, B.V. (2010). Pericytes control key neurovascular functions and
neuronal phenotype in the adult brain and during brain aging. Neuron 68,
409–427.
Berg, J.N., Gallione, C.J., Stenzel, T.T., Johnson, D.W., Allen, W.P., Schwartz,
C.E., Jackson, C.E., Porteous, M.E., and Marchuk, D.A. (1997). The activin
receptor-like kinase 1 gene: genomic structure and mutations in hereditary
hemorrhagic telangiectasia type 2. Am. J. Hum. Genet. 61, 60–67.
Bhowmick, N.A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C.A., Engel,
M.E., Arteaga, C.L., and Moses, H.L. (2001). Transforming growth factor-
beta1 mediates epithelial to mesenchymal transdifferentiation through
a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27–36.
Braun, A., Xu, H., Hu, F., Kocherlakota, P., Siegel, D., Chander, P., Ungvari, Z.,
Csiszar, A., Nedergaard, M., and Ballabh, P. (2007). Paucity of pericytes in
germinalmatrix vasculatureofpremature infants. J.Neurosci.27, 12012–12024.
Brown, R.C., Morris, A.P., and O’Neil, R.G. (2007). Tight junction protein
expression and barrier properties of immortalized mouse brain microvessel
endothelial cells. Brain Res. 1130, 17–30.
Carlson, M.E., Hsu, M., and Conboy, I.M. (2008). Imbalance between
pSmad3 and Notch induces CDK inhibitors in old muscle stem cells.
Nature 454, 528–532.
Crampton, S.P., Davis, J., and Hughes, C.C. (2007). Isolation of human umbil-
ical vein endothelial cells (HUVEC). J. Vis. Exp. 3, 183.
Dahlqvist, C., Blokzijl, A., Chapman, G., Falk, A., Dannaeus, K., Ibanez, C.F.,
and Lendahl, U. (2003). Functional Notch signaling is required for BMP4-
induced inhibition of myogenic differentiation. Development 130, 6089–6099.
Daneman, R., Zhou, L., Kebede, A.A., and Barres, B.A. (2010). Pericytes are
required for blood-brain barrier integrity during embryogenesis. Nature 468,
562–566.
Darland, D.C., and D’Amore, P.A. (2001). TGF beta is required for the formation
of capillary-like structures in three-dimensional cocultures of 10T1/2 and
endothelial cells. Angiogenesis 4, 11–20.pmental Cell 20, 291–302, March 15, 2011 ª2011 Elsevier Inc. 301
Developmental Cell
Endothelial Smad4 and Cerebrovascular Integrityde Jesus Perez, V.A., Alastalo, T.P., Wu, J.C., Axelrod, J.D., Cooke, J.P.,
Amieva, M., and Rabinovitch, M. (2009). Bone morphogenetic protein 2
induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1
pathways. J. Cell Biol. 184, 83–99.
De Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach,
C., Bruyneel, E., and Mareel, M. (2004). Critical role of N-cadherin in myofibro-
blast invasion and migration in vitro stimulated by colon-cancer-cell-derived
TGF-beta or wounding. J. Cell Sci. 117, 4691–4703.
Derynck, R., and Zhang, Y.E. (2003). Smad-dependent and Smad-indepen-
dent pathways in TGF-beta family signalling. Nature 425, 577–584.
Diamond, M.E., Sun, L., Ottaviano, A.J., Joseph, M.J., and Munshi, H.G.
(2008). Differential growth factor regulation of N-cadherin expression and
motility in normal and malignant oral epithelium. J. Cell Sci. 121, 2197–2207.
Dickson, M.C., Martin, J.S., Cousins, F.M., Kulkarni, A.B., Karlsson, S., and
Akhurst, R.J. (1995). Defective hematopoiesis and vasculogenesis in trans-
forming growth factor-beta 1 knock out mice. Development 121, 1845–1854.
Dwivedi, A., Slater, S.C., and George, S.J. (2009). MMP-9 and 12 cause
N-cadherin shedding and thereby beta-catenin signalling and vascular smooth
muscle cell proliferation. Cardiovasc. Res. 81, 178–186.
Fu, Y., Chang, A., Chang, L., Niessen, K., Eapen, S., Setiadi, A., and Karsan, A.
(2009). Differential regulation of transforming growth factor beta signaling
pathways by Notch in human endothelial cells. J. Biol. Chem. 284, 19452–
19462.
Gallione, C.J., Repetto, G.M., Legius, E., Rustgi, A.K., Schelley, S.L., Tejpar,
S., Mitchell, G., Drouin, E., Westermann, C.J., and Marchuk, D.A. (2004).
A combined syndrome of juvenile polyposis and hereditary haemorrhagic
telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363,
852–859.
Gerhardt, H., Wolburg, H., and Redies, C. (2000). N-cadherin mediates peri-
cytic-endothelial interaction during brain angiogenesis in the chicken. Dev.
Dyn. 218, 472–479.
Gridley, T. (2007). Notch signaling in vascular development and physiology.
Development 134, 2709–2718.
Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto,M., Nakahata, T.,
Ikuta, K., and Honjo, T. (2002). Inducible gene knockout of transcription factor
recombination signal binding protein-J reveals its essential role in T versus B
lineage decision. Int. Immunol. 14, 637–645.
Itoh, F., Itoh, S., Goumans, M.J., Valdimarsdottir, G., Iso, T., Dotto, G.P.,
Hamamori, Y., Kedes, L., Kato, M., and ten Dijke Pt, P. (2004). Synergy and
antagonism betweenNotch and BMP receptor signaling pathways in endothe-
lial cells. EMBO J. 23, 541–551.
Kurpinski, K., Lam, H., Chu, J., Wang, A., Kim, A., Tsay, E., Agrawal, S.,
Schaffer, D.V., and Li, S. (2010). Transforming growth factor-beta and notch
signaling mediate stem cell differentiation into smooth muscle cells. Stem
Cells 28, 734–742.
Lan, Y., Liu, B., Yao, H., Li, F., Weng, T., Yang, G., Li, W., Cheng, X., Mao, N.,
and Yang, X. (2007). Essential role of endothelial Smad4 in vascular remodel-
ing and integrity. Mol. Cell. Biol. 27, 7683–7692.
Larsson, J., Goumans, M.J., Sjostrand, L.J., van Rooijen, M.A., Ward, D.,
Leveen, P., Xu, X., ten Dijke, P., Mummery, C.L., and Karlsson, S. (2001).
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I
receptor-deficient mice. EMBO J. 20, 1663–1673.
Li, D.Y., Sorensen, L.K., Brooke, B.S., Urness, L.D., Davis, E.C., Taylor, D.G.,
Boak, B.B., and Wendel, D.P. (1999). Defective angiogenesis in mice lacking
endoglin. Science 284, 1534–1537.
Lindahl, P., Johansson, B.R., Leveen, P., and Betsholtz, C. (1997). Pericyte
loss and microaneurysm formation in PDGF-B-deficient mice. Science 277,
242–245.
Liu, Z.J., Xiao, M., Balint, K., Smalley, K.S., Brafford, P., Qiu, R., Pinnix, C.C.,
Li, X., and Herlyn, M. (2006). Notch1 signaling promotes primary melanoma
progression by activating mitogen-activated protein kinase/phosphati-
dylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Cancer Res. 66, 4182–4190.302 Developmental Cell 20, 291–302, March 15, 2011 ª2011 ElsevierLuna-Zurita, L., Prados, B., Grego-Bessa, J., Luxan, G., del Monte, G.,
Benguria, A., Adams, R.H., Perez-Pomares, J.M., and de la Pompa, J.L.
(2010). Integration of a Notch-dependent mesenchymal gene program and
Bmp2-driven cell invasiveness regulates murine cardiac valve formation.
J. Clin. Invest. 120, 3493–3507.
Luo, Y., and Radice, G.L. (2005). N-cadherin acts upstream of VE-cadherin in
controlling vascular morphogenesis. J. Cell Biol. 169, 29–34.
McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A.,
Jackson, C.E., Helmbold, E.A., Markel, D.S., McKinnon, W.C., Murrell, J.,
et al. (1994). Endoglin, a TGF-beta binding protein of endothelial cells, is the
gene for hereditary haemorrhagic telangiectasia type1.Nat.Genet.8, 345–351.
Meng, F., Shi, L., Cheng, X., Hou, N., Wang, Y., Teng, Y., Meng, A., and Yang,
X. (2007). Surfactant protein A promoter directs the expression of Cre recom-
binase in brain microvascular endothelial cells of transgenic mice. Matrix Biol.
26, 54–57.
Morgan, T., McDonald, J., Anderson, C., Ismail, M., Miller, F., Mao, R., Madan,
A., Barnes, P., Hudgins, L., andManning, M. (2002). Intracranial hemorrhage in
infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-
Rendu syndrome). Pediatrics 109, E12.
Nakagawa, S., Deli, M.A., Nakao, S., Honda, M., Hayashi, K., Nakaoke, R.,
Kataoka, Y., and Niwa, M. (2007). Pericytes from brain microvessels
strengthen the barrier integrity in primary cultures of rat brain endothelial cells.
Cell. Mol. Neurobiol. 27, 687–694.
Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L.,
Miyazono, K., ten Dijke, P., Kim, S., et al. (2000). Activin receptor-like kinase
1 modulates transforming growth factor-beta 1 signaling in the regulation of
angiogenesis. Proc. Natl. Acad. Sci. USA 97, 2626–2631.
Oshima, M., Oshima, H., and Taketo, M.M. (1996). TGF-beta receptor type II
deficiency results in defects of yolk sac hematopoiesis and vasculogenesis.
Dev. Biol. 179, 297–302.
Paik, J.H., Skoura, A., Chae, S.S., Cowan, A.E., Han, D.K., Proia, R.L., and Hla,
T. (2004). Sphingosine 1-phosphate receptor regulation of N-cadherin medi-
ates vascular stabilization. Genes Dev. 18, 2392–2403.
Rynkowski, M.A., Kim, G.H., Komotar, R.J., Otten, M.L., Ducruet, A.F.,
Zacharia, B.E., Kellner, C.P., Hahn, D.K., Merkow, M.B., Garrett, M.C., et al.
(2008). A mouse model of intracerebral hemorrhage using autologous blood
infusion. Nat. Protoc. 3, 122–128.
Song, L., and Pachter, J.S. (2003). Culture ofmurine brainmicrovascular endo-
thelial cells that maintain expression and cytoskeletal association of tight junc-
tion-associated proteins. In Vitro Cell. Dev. Biol. Anim. 39, 313–320.
Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter
strain. Nat. Genet. 21, 70–71.
Spindler, V., Schlegel, N., and Waschke, J. (2010). Role of GTPases in control
of microvascular permeability. Cardiovasc. Res. 87, 243–253.
Tang, Y., Urs, S., Boucher, J., Bernaiche, T., Venkatesh, D., Spicer, D.B., Vary,
C.P., and Liaw, L. (2010). Notch and transforming growth factor-beta
(TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle
cell differentiation. J. Biol. Chem. 285, 17556–17563.
Tillet, E., Vittet, D., Feraud, O., Moore, R., Kemler, R., and Huber, P. (2005).
N-cadherin deficiency impairs pericyte recruitment, and not endothelial differ-
entiation or sprouting, in embryonic stem cell-derived angiogenesis. Exp. Cell
Res. 310, 392–400.
Williams, H., Johnson, J.L., Jackson, C.L., White, S.J., and George, S.J.
(2010). MMP-7 mediates cleavage of N-cadherin and promotes smooth
muscle cell apoptosis. Cardiovasc. Res. 87, 137–146.
Yang, X., Castilla, L.H., Xu, X., Li, C., Gotay, J., Weinstein, M., Liu, P.P., and
Deng, C.X. (1999). Angiogenesis defects and mesenchymal apoptosis in
mice lacking SMAD5. Development 126, 1571–1580.
Yang, X., Li, C., Herrera, P.L., and Deng, C.X. (2002). Generation of Smad4/
Dpc4 conditional knockout mice. Genesis 32, 80–81.Inc.
